Malvern Panalytical Acquires Creoptix AG
January 11, 2022
Malvern Panalytical has acquired Creoptix AG, a Swiss specialist in next-generation bioanalytical sensors and the WAVEsystem instrumentation, to strengthen its drug discovery and biopharma capabilities. The acquisition integrates Creoptix's Grating-Coupled Interferometry (GCI) technology into Malvern Panalytical's portfolio to expand molecular interaction analysis offerings for pharmaceutical and life-sciences customers.
- Buyers
- Malvern Panalytical
- Targets
- Creoptix AG
- Industry
- Medical Devices
- Location
- Zurich, Switzerland
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Headwall Photonics Acquires Holographix LLC
June 30, 2022
Manufacturing
Headwall Photonics, a Bolton, Massachusetts-based manufacturer of hyperspectral imaging systems and holographic gratings, acquired Holographix LLC, a Marlborough, Massachusetts specialist in micro- and nano-structure replication. The acquisition expands Headwall's manufacturing capabilities and product portfolio—adding replication technology for microlens arrays, structured diffusers, waveguides, and replicated mirrors to serve life sciences, semiconductor, aerospace & defense, and metrology end markets.
-
Edgewater Capital Partners Acquires GL CHEMTEC
August 11, 2022
Pharmaceuticals
Edgewater Capital Partners, a Cleveland-based lower middle-market private equity firm, has acquired GL CHEMTEC, a chemistry-based contract research organization (CRO) headquartered in Oakville, Ontario. Edgewater will support GLC's expansion of API development, scale-up and advanced materials capabilities to accelerate growth across North American pharma and life-sciences customers.
-
Bruker Corporation Acquires Tornado Spectral Systems Inc.
January 4, 2024
Medical Devices
Bruker Corporation has acquired Tornado Spectral Systems Inc., a Mississauga, Ontario-based maker of process Raman instruments, to expand Bruker’s biopharma Process Analytical Technology (PAT) product portfolio. Financial terms were not disclosed; Tornado’s HTVS-enabled Raman analyzers and probes will be integrated into Bruker’s spectroscopy and biopharma offerings to enhance process monitoring and quality control capabilities.
-
BioAgilytix Acquires Cambridge Biomedical
November 4, 2019
Healthcare Services
BioAgilytix, a GHO Capital portfolio company, has acquired Cambridge Biomedical, a Cambridge, Massachusetts–based clinical research organisation specializing in large-molecule bioanalysis. The deal expands BioAgilytix's laboratory capacity and capabilities (including CLIA/CAP/GLP capabilities and PCR/molecular suites), broadens its geographic footprint into the Boston/Cambridge biotech cluster, and strengthens its cell- and gene-therapy bioanalytical offerings.
-
Scantox Group Acquires Gentronix Ltd
September 9, 2024
Healthcare Services
Scantox Group, together with its majority owner Impilo, has acquired Gentronix Ltd, a UK-based GLP-compliant genetic toxicology CRO headquartered at Alderley Park. The acquisition expands Scantox's preclinical service platform by adding specialist genetic, skin and ocular toxicology capabilities, bringing the Scantox Group to more than 400 employees across seven European sites.
-
908 Devices Acquires TRACE Analytics GmbH
August 9, 2022
Medical Devices
908 Devices (Nasdaq: MASS) has completed the acquisition of TRACE Analytics GmbH, a Braunschweig, Germany-based provider of on-line aseptic sampling systems and biosensors for bioreactor monitoring. The purchase consideration includes $15.3 million in cash up front plus up to $2.0 million of contingent consideration, and 908 Devices says the acquisition will enable its mass spec devices to perform on-line bioprocess monitoring and advance its bioanalytics platform.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.